Ignite Creation Date:
2024-05-06 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05252390
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2022-01-28
Brief Title:
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Sponsor:
Nuvation Bio Inc
Organization:
Nuvation Bio Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-28
First Submit QC Date:
February 11 2022
Study First Post Date:
2022-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-30
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL